On Sept. 30, 2026, the South China Morning Post reported that for the first time, China’s spending on…
On Sept. 30, 2026, Thewaico, a bioprocess innovation company, today emerged from stealth with an integrated bioreactor and…
On Sept. 29, 2026, China is offering the world’s brightest young scientists generous 15-year research grants for free…
On Sept. 28, 2026, Massachusetts Institute of Technology (MIT) engineers announced finding a way to stabilize the lipid…
On Sept. 28, 2026, AN2 Therapeutics, a clinical stage pharmaceutical company focused on the discovery and development of…
On Sept. 28, 2026, Harvard University announces a $150 million strategic research initiative is seeking to bolster pioneering…
On Sept. 25, 2026, the Pennsylvania Department of Health (DOH) reports 890 confirmed measles cases across 39 counties…
On Sept. 25, 2026, the World Health Organization (WHO) announced its recommendations for the viral composition of influenza…
On Sept. 25, 2026, the US Food and Drug Administration announced approval of AbbVie’s treatment for Parkinson’s disease…
On Sept. 24, 2026, a world-first test developed by researchers at the Garvan Institute of Medical Research has…
On Sept. 24, 2026, Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) approval of Onswik™ (insulin…
On Sept. 24, 2026, a new study from Washington University School of Medicine in St. Louis of nearly…
On Sept. 23, 2026, SystImmune announces the U.S. Food and Drug Administration (FDA) has cleared its Investigational New…
On Sept. 23, 2026, research led by Mount Sinai scientists within the PsychAD Consortium, a large-scale, multidisciplinary initiative…
On Sept. 21, 2026, the U.S. Department of Health and Human Services (HHS) announced a new wave of…
On Sept. 18, 2026, Eli Lilly and Company announced that the U.S. Food and Drug Administration(FDA) has granted…
On Sept. 17, 2026, Ultragenyx Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) granted standard full…
On Sept. 17, 2026, investigators at Dana-Farber Cancer Institute and 23andMe Research Institute report that a rare inherited…
On Sept. 17, 2026, Bayer announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA® (finerenone) to…
On Sept. 16, 2026, an analysis of more than 60,000 respiratory syncytial virus (RSV) sequences from around the…
On Sept. 16, 2026, a new discovery by neuroscientists at Brown University’s Carney Institute for Brain Science challenges…
On Sept. 16, 2026, researchers at Maynooth University (MU) have developed a first-of-its-kind DNA computer, described as one…
On Sept. 15, 2026, Oregon billionaires Phil and Penny Knight committed $1.1 billion to the Providence St. Vincent…
On Sept. 15, 2026, the Pennsylvania Department of Health (DOH) confirmed two additional measles-associated deaths in Pennsylvania. Both…
On Sept. 15, 2026, the U.S. Food and Drug Administration announced the final design of the Expedited Investigational…
On Sept. 14, 2026, bacteria that cause potentially fatal Legionnaires’ disease were found in a Yankee Stadium cooling…
On Sept. 14, 2026, Telix today announces that the U.S. Food and Drug Administration (FDA) has approved its…
On Sept. 11, 2026, the Pennsylvania Department of Health (DOH) announced that 676 measles cases have been confirmed…
On Sept. 10, 2026, philanthropist and entrepreneur Tom Golisano announced a $225 million investment in six children’s hospitals,…
On Sept. 10, 2026, Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced plans to further…